Magnetic resonance imaging predictors of disability in primary progressive multiple sclerosis: a 5-year study

Abstract

Magnetic resonance imaging (MRI) has become an accepted tool for monitoring therapeutic trials in relapsing-remitting and secondary progressive multiple sclerosis (MS); it is however unclear whether such MRI markers are equally applicable to primary progressive MS (PPMS). Forty-two patients with PPMS were reviewed five years after commencing a two-year MRI and clinical study. Clinical measures recorded at baseline and five years included both the Expanded Disability Status Scale and the MS functional composite. MRI data collected at baseline and two years included T1 and T2 lesion loads, the number of new brain and cord lesions, and measures of both brain and cord atrophy. The study demonstrated that both the number of new T2 lesions and rate of increase in ventricular volume over two years were modestly predictive of subsequent disease progression and therefore may be useful tools in the testing of new therapeutic agents in PPMS.

Keywords

disability MRI primary progressive multiple sclerosis

Get full access to this article

View all access options for this article.

References

Thompson AJ , Kermode AG , Wicks D , MacManus DG , Kendall BE , Kingsley DP et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis . Ann Neurol 1991; 29: 53-62 .

Lycklama a Nijeholt GJ , van Walderveen MA , Castelijns JA , van Waesberghe JH , Polman C , Scheltens P et al. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms . Brain 1998; 121: 687-697 .

Rovaris M , Bozzali M , Santuccio G , Ghezzi A , Caputo D , Montanari E et al. In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis . Brain 2001; 124: 2540-2549 .

Kalkers NF , Bergers E , Castelijns JA , van Walderveen MA , Bot JC , Ader HJ et al. Optimizing the association between disability and biological markers of MS . Neurology 2001; 57: 1253-1258 .

Stevenson VL , Miller DH , Rovaris M , Barkhof F , Brochet B , Dousset V et al. Primary progressive multiple sclerosis; a clinical and MRI cross sectional study . Neurology 1999; 52: 839-845 .

Stevenson VL , Miller DH , Leary SM , Rovaris M , Barkhof F , Brochet B et al. One year follow up study of primary and transitional progressive multiple sclerosis . J Neurol Neurosurg Psychiatry 2000; 68: 713-718 .

Ingle GT , Stevenson VL , Miller DH , Leary SM , Rovaris M , Barkhof F et al. Two-year follow-up study of primary and transitional progressive multiple sclerosis . Multiple Sclerosis 2002; 8: 108-114 .

Ingle GT , Stevenson VL , Miller DH , Thompson AJ. Primary progressive multiple sclerosis: a 5-year clinical and MRI study . Brain 2003; 126: 1-9 .

Leary SM , Miller DH , Thompson AJ. Design of a study of interferon beta-1a in primary progressive multiple sclerosis . J Neurol 1997; 244: S63-S63 .

10.

McFarland HF , Barkhof F , Antel J , Miller DH. The role of MRI as a surrogate outcome measure in multiple sclerosis . Multiple Sclerosis 2002; 8: 40-51 .

11.

Losseff NA , Kingsley DP , McDonald WI , Miller DH , Thompson AJ. Clinical and magnetic resonance imaging predictors of disability in primary and secondary progressive multiple sclerosis . Multiple Sclerosis 1996; 1: 218-222 .

12.

Stevenson VL , Smith SM , Matthews PM , Miller DH , Thompson AJ. Monitoring disease activity and progression in primary progressive multiple sclerosis using MRI: sub-voxel registration to identify lesion changes and to detect cerebral atrophy . J Neurol 2002; 249: 171-177 .

13.

Paty DW , Koopmans RA , Redekop WK , Oger JJF , Kastrukoff LF , Li DKB.

Does the MRI activity rate predict the clinical course of MS?

Neurology 1992; 42: 427-427 .

14.

Khoury SJ , Guttmann CR , Orav EJ , Hohol MJ , Ahn SS , Hsu L et al. Longitudinal MRI in multiple sclerosis: correlation between disability and lesion burden . Neurology 1994; 44: 2120-2124 .

15.

Rudick RA , Fisher E , Lee JC , Duda JT , Simon J. Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon beta-1a . Multiple Sclerosis 2000; 6: 365-372 .

16.

Fisher E , Rudick RA , Cutter G , Baier M , Miller D , Weinstock-Guttman B et al. Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients . Multiple Sclerosis 2000; 6: 373-377 .